investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
+
-
Project leads
Collaborators
Development of Novel Therapeutic Strategies in Human Leukemias
Benjamin Levine Ebert
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Bruno Calabretta
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
Leukaemia
Pathology
Hematology and hematologic malignancies
Harlan S. Robins
Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leukemia
Leukaemia
Ann Mullally
Functional and Molecular Dissection of Myeloproliferative Neoplasm Stem Cells
Leukaemia
Birgit Knoechel
Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia
Leukaemia
Nora C Heisterkamp
Role of Sialic Acid Modification in ALL Survival and Drug Resistance
Leukaemia
Pathology
Hematology and hematologic malignancies
Dan Landau
The role of epigenetic heterogeneity in CLL evolution
Leukaemia
Ross L Levine
Role of TET2 mutations in malignant transformation and acute myeloid leukemia
Leukaemia
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Pathology
Hematology and hematologic malignancies
M. James You
CHARACTERIZATION AND TARGETED THERAPY OF T-ALL DEFICIENT FOR PTEN AND INK4A/ARF
Leukaemia